BenQ Medical Technology Corp.(TW:4116)
NT$40.70-0.25 (-0.61%)
TW:4116
BenQ Medical Technology Corp. financials statements
NT$40.70
At close:-0.25 (-0.61%)
BenQ Medical Technology Corp. (4116) Income Statement
BenQ Medical Technology Corp. Income Statement
Last quarter (Q2 2026), BenQ Medical Technology Corp.'s total revenue was NT$1.43B, an increase of 7.06% from the same quarter last year. In Q2, BenQ Medical Technology Corp.'s net income was NT$58.98M. See BenQ Medical Technology Corp.’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| NT$ 5.25B | NT$ 4.77B | NT$ 4.54B | NT$ 2.95B | NT$ 1.46B | |
| NT$ 1.69B | NT$ 1.45B | NT$ 1.34B | NT$ 860.25M | NT$ 512.28M | |
| NT$ 1.35B | NT$ 1.11B | NT$ 978.46M | NT$ 681.13M | NT$ 465.82M | |
| Depreciation and Amortization | NT$ 269.13M | NT$ 255.21M | NT$ 229.22M | NT$ 190.01M | NT$ 101.04M |
| NT$ 611.55M | NT$ 618.82M | NT$ 624.71M | NT$ 476.65M | NT$ 166.74M | |
| NT$ 342.42M | NT$ 333.39M | NT$ 365.44M | NT$ 179.12M | NT$ 49.06M | |
| NT$ -7.84M | NT$ -4.01M | NT$ -55.27M | NT$ 95.77M | NT$ 12.73M | |
| NT$ 334.58M | NT$ 329.38M | NT$ 310.17M | NT$ 274.89M | NT$ 61.78M | |
| NT$ 78.17M | NT$ 104.83M | NT$ 114.58M | NT$ 180.24M | NT$ 28.84M | |
| Per Share Metrics | |||||
| Basic EPS | NT$ 1.75 | NT$ 2.36 | NT$ 2.57 | NT$ 4.04 | NT$ 0.65 |
| Diluted EPS | NT$ 1.75 | NT$ 2.34 | NT$ 2.56 | NT$ 4.02 | NT$ 0.65 |
| Weighted Average Shares Outstanding | 124.36M | 44.40M | 44.58M | 44.57M | 44.56M |
| Weighted Average Shares Outstanding (Diluted) | 124.36M | 44.40M | 44.82M | 44.85M | 44.66M |
Currency in TWD

